» Articles » PMID: 22200330

Gold Nanoparticles Generated and Stabilized by Water Soluble Curcumin-polymer Conjugate: Blood Compatibility Evaluation and Targeted Drug Delivery Onto Cancer Cells

Overview
Specialty Chemistry
Date 2011 Dec 28
PMID 22200330
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin (Cur) shows low anticancer activity in vivo due to its reduced systemic bioavailability stemmed from its poor aqueous solubility and instability. Suitably functionalized nanocarriers designed to empty the drug specifically at tumor sites can potentially enhance the antitumor activity of Cur. We devised a simple method for the fabrication of water soluble Cur conjugated gold nanoparticles to target various cancer cell lines. Cur was conjugated to hyaluronic acid (HA) to get a water soluble conjugate (HA-Cur). We generated gold nanoparticles (AuNPs) by reducing chloroauric acid using HA-Cur, which played the dual role of a reducing and stabilizing agent and subsequently anchored folate conjugated PEG. These entities were probed using different analytical techniques, assayed the blood compatibility and cytotoxicity. Their interaction with cancer cell lines (HeLa cells, glyoma cells and Caco 2 cells) was followed by flow cytometry and confocal microscopy. Blood-materials interactions studies showed that the nanoparticles are highly hemocompatible. Flow cytometry and confocal microscopy results showed significant cellular uptake and internalization of the particles by cells. HA-Cur@AuNPs exhibited more cytotoxicity comparing to free Cur. The strategy, we adopted here, resulted the formation blood compatible Cur conjugated AuNPs with enhanced targeting and improved efficacy.

Citing Articles

Surface Chemistry of Gold Nanoparticles Modulates Cytokines and Nanomechanical Properties in Pancreatic Cancer Cell Lines: A Correlative Study.

Kulkarni T, Angom R, Wang E, Mukhopadhyay D, Bhattacharya S Fortune J Health Sci. 2024; 7(1):112-127.

PMID: 38706513 PMC: 11065124. DOI: 10.26502/fjhs.170.


Recent nanotheranostic approaches in cancer research.

Gupta D, Roy P, Sharma R, Kasana R, Rathore P, Gupta T Clin Exp Med. 2024; 24(1):8.

PMID: 38240834 PMC: 10799106. DOI: 10.1007/s10238-023-01262-3.


Molecular Biomarkers of Bladder Cancer: A Mini-Review.

Varchulova Novakova Z, Kuniakova M, Ziaran S, Harsanyi S Physiol Res. 2023; 72(S3):S247-S256.

PMID: 37888968 PMC: 10669948. DOI: 10.33549/physiolres.935187.


Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid-Quercetin-Conjugated Silver Nanoparticles.

Al-Serwi R, Eladl M, El-Sherbiny M, Saleh M, Othman G, Alshahrani S Molecules. 2023; 28(10).

PMID: 37241888 PMC: 10221215. DOI: 10.3390/molecules28104146.


Combined Self-Assembled Hendeca-Arginine Nanocarriers for Effective Targeted Gene Delivery to Bladder Cancer.

Zhang P, Zhang H, Zheng B, Wang H, Qi X, Wang S Int J Nanomedicine. 2022; 17:4433-4448.

PMID: 36172006 PMC: 9512291. DOI: 10.2147/IJN.S379356.